![Peter G. Linde](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Peter G. Linde
Corporate Officer/Principal chez
Walden Biosciences, Inc.
Profil
Peter G.
Linde is currently the Chief Medical Officer at Walden Biosciences, Inc. He previously worked as the Senior Director-Clinical Development at FibroGen, Inc. and as the Vice President-Medical Research at Acceleron Pharma, Inc. From 2020 to 2021, he served as the Chief Medical Officer at Morphic Holding, Inc. Linde received his undergraduate degree from the Massachusetts Institute of Technology.
Postes actifs de Peter G. Linde
| Sociétés | Poste | Début |
|---|---|---|
Walden Biosciences, Inc.
 Walden Biosciences, Inc. Medical/Nursing ServicesHealth Services Provides renal therapeutics services | Corporate Officer/Principal | 11/10/2022 |
Anciens postes connus de Peter G. Linde
| Sociétés | Poste | Fin |
|---|---|---|
| MORC HOLD | Directeur Technique/Scientifique/R&D | 31/12/2021 |
| KYNTRA BIO, INC. | Corporate Officer/Principal | - |
| ACCELERON PHARMA INC. | Corporate Officer/Principal | - |
Formation de Peter G. Linde
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
1
Relations au 1er degré
5
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Acceleron Pharma, Inc.
 Acceleron Pharma, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company which develops protein therapeutics for cancer and orphan diseases | Health Technology |
FibroGen, Inc.
 FibroGen, Inc. Pharmaceuticals: MajorHealth Technology Develops biotechnology-based drugs | Health Technology |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Morphic Holding, Inc.
 Morphic Holding, Inc. Pharmaceuticals: MajorHealth Technology Develops oral integrin drugs | Health Technology |
Walden Biosciences, Inc.
Walden Biosciences, Inc. Medical/Nursing ServicesHealth Services Provides renal therapeutics services | Health Services |
